These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5776642)

  • 1. Norepinephrine: release from brain by d-amphetamine in vivo.
    Carr LA; Moore KE
    Science; 1969 Apr; 164(3877):322-3. PubMed ID: 5776642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of amphetamine on the contents of norepinephrine and its metabolites in the effluent of perfused cerebral ventricles of the cat.
    Carr LA; Moore KE
    Biochem Pharmacol; 1970 Jul; 19(7):2361-74. PubMed ID: 5520379
    [No Abstract]   [Full Text] [Related]  

  • 3. D-amphetamine-induced release of "newly synthesized" and "stored" dopamine from the caudate nucleus in vivo.
    Chiueh CC; Moore KE
    J Pharmacol Exp Ther; 1975 Mar; 192(3):642-53. PubMed ID: 1120962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 2, 5-dimethoxy-4-methylamphetamine (DOM) and d-amphetamine for in vivo efflux of catecholamines from rat brain.
    Vrbanac JJ; Tilson HA; Moore KE; Rech RH
    Pharmacol Biochem Behav; 1975; 3(1):57-64. PubMed ID: 1129355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo release of endogenously synthesized catecholamines from the cat brain evoked by electrical stimulation and by d-amphetamine.
    Chiueh CC; Moore KE
    J Neurochem; 1974 Jul; 23(1):159-68. PubMed ID: 4852387
    [No Abstract]   [Full Text] [Related]  

  • 6. Release of norepinephrine and normetanephrine from cat brain by central nervous system stimulants.
    Carr LA; Moore KE
    Biochem Pharmacol; 1970 Sep; 19(9):2671-5. PubMed ID: 4394597
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of alpha-methyltyrosine on d-amphetamine-induced release of endogenously synthesized and exogenously administered catecholamines from the cat brain in vivo.
    Chiueh CC; Moore KE
    J Pharmacol Exp Ther; 1974 Jul; 190(1):100-8. PubMed ID: 4847307
    [No Abstract]   [Full Text] [Related]  

  • 8. Schedule controlled and drug induced release of norepinephrine-7- 3 H into the lateral ventricle of rats.
    Sparber SB; Tilson HA
    Neuropharmacology; 1972 Jul; 11(4):453-64. PubMed ID: 5047938
    [No Abstract]   [Full Text] [Related]  

  • 9. Appearance of 5-hydroxytryptamine and an unidentified pharmacologically active lipid acid in effluent from perfused cerebral ventricles.
    Feldberg W; Myers RD
    J Physiol; 1966 Jun; 184(4):837-55. PubMed ID: 5296524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of effect of amantadine on d-amphetamine-induced release of dopamine from cat brain in vivo.
    Gudelsky GA; McCall RB; Chiueh CC; Moore KE
    Res Commun Chem Pathol Pharmacol; 1974 Dec; 9(4):653-60. PubMed ID: 4456497
    [No Abstract]   [Full Text] [Related]  

  • 11. A simple and rapid method for injecting H3-norepinephrine into the lateral ventricle of the rat brain.
    Noble EP; Wurtman RJ; Axelrod J
    Life Sci; 1967 Feb; 6(3):281-91. PubMed ID: 6071872
    [No Abstract]   [Full Text] [Related]  

  • 12. Dopamine: release from the brain in vivo by amantadine.
    Von Voigtlander PF; Moore KE
    Science; 1971 Oct; 174(4007):408-10. PubMed ID: 5111993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nicotine on the release of 3 H-noradrenaline from the hypothalamus.
    Hall GH; Turner DM
    Biochem Pharmacol; 1972 Jul; 21(13):1829-38. PubMed ID: 4646185
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo release of newly synthesized catecholamines from the hypothalamus by amphetamine.
    Philippu A; Glowinski J; Besson MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(1):1-8. PubMed ID: 4275627
    [No Abstract]   [Full Text] [Related]  

  • 15. Distribution and metabolism of norepinephrine after its administration into the cerebroventricular system of the cat.
    Carr LA; Moore KE
    Biochem Pharmacol; 1969 Aug; 18(8):1907-18. PubMed ID: 4390276
    [No Abstract]   [Full Text] [Related]  

  • 16. Perfusion of cerebral ventricles: assay of pharmacologically active substances in the effluent from the cisterna and the aqueduct.
    BHATTACHARYA BK; FELDBERG W
    Br J Pharmacol Chemother; 1958 Jun; 13(2):163-74. PubMed ID: 13536281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of norepinephrine re-uptake by angiotensin in brain.
    Palaic D; Khairallah PA
    J Neurochem; 1968 Oct; 15(10):1195-202. PubMed ID: 4304049
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the concurrent behavioral and neurochemical effects of psychoactive drugs using the push-pull cannula.
    Tilson HA; Sparber SB
    J Pharmacol Exp Ther; 1972 Jun; 181(3):387-98. PubMed ID: 5033008
    [No Abstract]   [Full Text] [Related]  

  • 19. Norepinephrine elevations in cerebrospinal fluid after d- and l-amphetamine.
    Ziegler MG; Lake CR; Ebert MH
    Eur J Pharmacol; 1979 Aug; 57(2-3):127-33. PubMed ID: 114399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of nigro-striatal neurons in the in vivo release of dopamine by amphetamine, amantadine and tyramine.
    Von Voigtlander PF; Moore KE
    J Pharmacol Exp Ther; 1973 Mar; 184(3):542-52. PubMed ID: 4687219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.